Literature DB >> 17049387

Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis.

Christian Bruch1, Markus Rothenburger, Michael Gotzmann, Thomas Wichter, Hans H Scheld, Günter Breithardt, Rainer Gradaus.   

Abstract

BACKGROUND: In patients with chronic heart failure (CHF), chronic kidney disease (CKD) is associated with increased morbidity and mortality, but contributing mechanisms are not well defined. This study tested the impact of CKD on intracardiac conduction, diastolic function and prognosis in patients with underlying CHF.
METHODS: We prospectively enrolled 269 patients with stable CHF, of whom 135 had CKD (estimated glomerular filtration rate (eGFR)<60 ml/min/1.73 m(2)). Echo measurements comprised left ventricular dimensions/volumes, ejection fraction, mitral E/A-ratio, deceleration time and tissue Doppler mitral annular velocities (S', E', A'). PQ and QRS intervals were derived from the 12-lead ECG. A cardiac event (cardiac death or urgent cardiac transplantation) was defined as combined study end point.
RESULTS: Patients with CKD had longer PQ and QRS intervals, and were in a poorer NYHA functional class as compared to patients without CKD. In patients with CKD, the mitral annular E' velocity was lower, the mitral E/E'-ratio was higher and a restrictive mitral filling pattern was more frequent. By linear regression analysis, PQ and QRS intervals and the mitral E/E'-ratio were inversely related to the eGFR. During a follow-up of 507+/-375 days, 39 patients suffered a cardiac event. In CKD patients, outcome was markedly poorer as compared to those without CKD (event-free survival rate 51% vs. 87% in those without KD, p=0.001)
CONCLUSIONS: In patients with CHF, CKD is associated with impaired intracardiac conduction and progressive diastolic dysfunction. Both mechanisms may contribute to increased morbidity and mortality of such patients.

Entities:  

Mesh:

Year:  2006        PMID: 17049387     DOI: 10.1016/j.ijcard.2006.06.066

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

1.  Change in comorbidity prevalence with advancing age among persons with heart failure.

Authors:  Sangeeta C Ahluwalia; Cary P Gross; Sarwat I Chaudhry; Linda Leo-Summers; Peter H Van Ness; Terri R Fried
Journal:  J Gen Intern Med       Date:  2011-05-15       Impact factor: 5.128

2.  Associations between increased renal resistive index and cardiovascular events.

Authors:  Kaoru Komuro; Noriko Yokoyama; Misaki Shibuya; Kazuyuki Soutome; Masanori Hirose; Kazuya Yonezawa; Teisuke Anzai
Journal:  J Med Ultrason (2001)       Date:  2015-10-22       Impact factor: 1.314

3.  Gender differences of pulsed and tissue Doppler indexes of left ventricular diastolic function in healthy subjects.

Authors:  Takenori Otsuka; Makoto Suzuki; Hisao Yoshikawa; Kaoru Sugi
Journal:  J Echocardiogr       Date:  2009-12-12

Review 4.  Heart failure with preserved ejection fraction: a nephrologist-directed primer.

Authors:  Baris Afsar; Patrick Rossignol; Loek van Heerebeek; Walter J Paulus; Kevin Damman; Stephane Heymans; Vanessa van Empel; Alan Sag; Alan Maisel; Mehmet Kanbay
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

5.  Antihypertensive treatment improves left ventricular diastolic function in patients with chronic kidney disease.

Authors:  Ku-Lin Li; Ru-Xing Wang; Min Dai; Juan Lu; Jing Xue; Xiang-Jun Yang
Journal:  Exp Ther Med       Date:  2015-03-02       Impact factor: 2.447

Review 6.  Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease.

Authors:  David Charytan
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

Review 7.  Clinical practice: heart failure in children. Part I: clinical evaluation, diagnostic testing, and initial medical management.

Authors:  Paul F Kantor; Luc L Mertens
Journal:  Eur J Pediatr       Date:  2009-08-26       Impact factor: 3.183

8.  Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.

Authors:  David H Smith; Micah L Thorp; Jerry H Gurwitz; David D McManus; Robert J Goldberg; Larry A Allen; Grace Hsu; Sue Hee Sung; David J Magid; Alan S Go
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-05-17

9.  Association of mild to moderate kidney dysfunction and coronary calcification.

Authors:  Joachim H Ix; Ronit Katz; Bryan Kestenbaum; Linda F Fried; Holly Kramer; Catherine Stehman-Breen; Michael G Shlipak
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

10.  Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.

Authors:  Erin D Unger; Ruth F Dubin; Rajat Deo; Vistasp Daruwalla; Julie L Friedman; Crystal Medina; Lauren Beussink; Benjamin H Freed; Sanjiv J Shah
Journal:  Eur J Heart Fail       Date:  2015-12-03       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.